landiolol has been researched along with Hypoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, S; Kurita, T; Morita, K; Nakajima, Y | 1 |
| Kurita, T; Morita, K; Sato, S | 1 |
2 other study(ies) available for landiolol and Hypoxia
| Article | Year |
|---|---|
Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Apnea; Cerebrum; Disease Models, Animal; Dobutamine; Hypoxia; Morpholines; Oxygen Consumption; Spectroscopy, Near-Infrared; Swine; Urea | 2017 |
Impact of a β-blocker and/or acute hemodilution on cerebral oxygenation during apneic hypoxia.
Topics: Adrenergic beta-Antagonists; Animals; Apnea; Brain; Hemodilution; Hypoxia; Morpholines; Oxygen; Spectroscopy, Near-Infrared; Swine; Urea | 2016 |